Home › Knight Therapeutics reacquires leishmaniasis drug Impavido
 

Keywords :   


Knight Therapeutics reacquires leishmaniasis drug Impavido

2016-03-16 02:20:59| Agriculture - Topix.net

Jonathan Ross Goodman is president and CEO and Jeffrey Kadanoff is CFO of Knight Therapeutics. The Montreal drug distributor has bought back the distribution rights to Impavido, a treatment for the rare parasitic disease leishmaniasis.

Tags: drug knight therapeutics reacquires

Category:Agriculture and Forestry

Latest from this category

All news
27.11Washington Corner | November 2024
27.11Terminal crossbreeding: A missed opportunity
27.11Feedlot Forum 2025 features Cattle feeding in a changing environment
27.11Smithfield Foods continues support for Mayflower Marathon Holiday Food Drive
27.11Researchers turn to AI to optimize hog selling
27.11H5N1 in pigs: Where are the knowledge gaps?
26.11New swine respiratory disease treatment flexibility from nursery to finish
26.11Panel talks capturing added value in cattle
Agriculture and Forestry »
27.11Washington Corner | November 2024
27.11
27.11MTG 4
27.1119
27.11
27.11Y-3
27.11
27.1125th PSA10
More »